Literature DB >> 7005520

Inhibition of mitogen-induced lymphokine production by cyclosporin A.

L H Block, W Siegenthaler, J Drews.   

Abstract

The new antilymphocytic agent Cyclosporin A was found to inhibit the production and/or secretion of migration inhibitory factor (MIF) in human lymphocytes stimulated by Concanavalin A. Preincubation for one hour with the compound, followed by 8 hr restoration period of the cells in absence of the drug, resulted in moderate decrease in MIF synthesis and/or release. Cell viability was not affected. The agent was shown not to interfere with MIF action on the macrophage. We conclude that the molecular mechanism of action of Cyclosporin A is based, at least partially, on a blockade of synthesis and/or secretion of lymphokines from immunocompetent cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005520     DOI: 10.1007/bf01478462

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Production and in vivo effect of antibodies against guinea pig lymphokines.

Authors:  C L Geczy; W Friedrich; A L de Weck
Journal:  Cell Immunol       Date:  1975-09       Impact factor: 4.868

2.  Cyclosporin A -- a new outlook for immunosuppresion in clinical transplantation.

Authors:  P J Tutschka
Journal:  Blut       Date:  1979-08

3.  Activation of suppressor T cells by tumour cells and specific antibody.

Authors:  R K Gershon; M B Mokyr; M S Mitchell
Journal:  Nature       Date:  1974-08-16       Impact factor: 49.962

4.  The mechanism of action of soluble lymphocytic mediators. II. Modification of macrophage migration and migration inhibitory factor action by drugs, enzymes and cationic environment.

Authors:  E Pick; S Manheimer
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

5.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

6.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

7.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

8.  Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A.

Authors:  R Y Calne; D J White; K Rolles; D P Smith; B M Herbertson
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

9.  Suppression of delayed hypersensitivity in vitro by inhibition of protein synthesis.

Authors:  J R David
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

10.  Human migration inhibitory factor: purification and immunochemical characterization.

Authors:  L H Block; H Jaksche; S Bamberger; G Ruhenstroth-Bauer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  2 in total

1.  Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes.

Authors:  J F Gauchat; E W Khandjian; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.